US Army Medical Research Institute of Chemical Defense (USAMRICD) has issued an intent to award a sole source contract to Brentwood Biomedical Research Institute (BBRI) of Los Angeles, CA.
The services are in support of an on-going research protocol investigating the time course and mechanism of neuronal damage associated with chemical agent-induced seizures. The project is being executed under an interagency agreement between USAMRICD and the Biomedical Advanced Research and Development Authority (BARDA).
BBRI is currently collaborating with the USAMRICD to evaluate the effects of organophosphates and chemical warfare agents in the adult animal brain. The contract will allow for comparisons between juvenile and older animals, using the same techniques and quantification methods already in place.
BBRI scientists have extensive experience in neuronal injury, mechanisms of seizure-induced neuronal death in the immature brain, and in differentiating neuronal necrosis from neuronal apoptosis. The company is also recognized as leading researchers on seizure-based animal models.
- View Profile: US Army Medical Research Institute of Chemical Defense
- View Profile: Biomedical Advanced Research and Development Authority
